Related Experiment Video
Updated: Apr 14, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Cardiovascular effects of methotrexate in rheumatoid arthritis revisited
Tatyana V Popkova1, Diana S Novikova, Armen Yuri Gasparyan
1Department of Vascular Pathology of Rheumatic Diseases, V.A. Nasonova Research Institute of Rheumatology, Russian Academy Sciences, Kashirskoe Shosse, 34A, Moscow, 115522, Russian Federation. popkovatv@mail.ru.
Abstract:
Cardiovascular events such as myocardial infarction (MI) and stroke due to enhanced inflammatory atherosclerosis account for increased premature mortality in rheumatoid arthritis (RA). Accumulated evidence suggests that accelerated atherosclerosis and related cardiovascular comorbidities in RA are confounded not only by traditional risk factors (TRF) but also by a number of immune and inflammatory pathways. Since chronic inflammation and autoimmune disorders play a key role in atherosclerosis and related cardiovascular complications in RA, effective suppression of systemic inflammation can be viewed as a strategy for cardiovascular therapy and prevention in this disease. This article overviews some mechanisms of action of methotrexate on TRF, clinical and subclinical manifestations of RA-induced atherosclerosis, and related cardiovascular morbidity and mortality.
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Therapeutic Drug Monitoring: Affecting Factors
Rheumatic Heart Disease I: Introduction
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Rheumatic Heart Disease IV: Nursing Management

